Journal
SCIENCE
Volume 322, Issue 5899, Pages 268-271Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1164164
Keywords
-
Categories
Funding
- NIH [F30NS061471, R01EY05945, R01EY015291, P30EY08098]
- Research to Prevent Blindness Medical Student Eye Research Fellowship
- Eye and Ear Foundation of Pittsburgh
Ask authors/readers for more resources
Reactivation of herpes simplex virus type 1 (HSV-1) from neuronal latency is a common and potentially devastating cause of disease worldwide. CD8(+) T cells can completely inhibit HSV reactivation in mice, with interferon-gamma affording a portion of this protection. We found that CD8(+) T cell lytic granules are also required for the maintenance of neuronal latency both in vivo and in ex vivo ganglia cultures and that their directed release to the junction with neurons in latently infected ganglia did not induce neuronal apoptosis. Here, we describe a nonlethal mechanism of viral inactivation in which the lytic granule component, granzyme B, degrades the HSV-1 immediate early protein, ICP4, which is essential for further viral gene expression.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available